Literature DB >> 18852250

Vaccine-induced cellular immune responses differ from innate responses in susceptible and resistant strains of mice infected with Coccidioides posadasii.

Lisa F Shubitz1, Sharon M Dial, Robert Perrill, Rachael Casement, John N Galgiani.   

Abstract

Susceptibility to Coccidioides spp. varies widely in humans and other mammals and also among individuals within a species. Among strains of mice with various susceptibilities, immunohistopathology revealed that C57BL/6 mice were highly susceptible to the disease following intranasal infection, DBA/2n mice were intermediate, and Swiss-Webster mice were innately resistant. Resistant Swiss-Webster mice developed prominent perivascular/peribronchiolar lymphocytic cuffing and well-formed granulomas with few fungal elements and debris in the necrotic center, surrounded by a mantle of macrophages, lymphocytes, and fibrocytes. Susceptible C57BL/6 mice became moribund between 14 and 18 days postinfection, with overwhelming numbers of neutrophils and spherules and very few T cells, the drastic reduction of which was associated with failure and death, while intermediate DBA/2n mice controlled the fungal burden but demonstrated progressive lung inflammation with prominent suppuration, and they deteriorated clinically. Vaccinated C57BL/6 mice had an early and robust lymphocyte response, which included significantly higher Mac2(+), CD3(+), and CD4(+) cell scores on day 18 than those of innately resistant SW mice and DBA/2n mice; they also had prominent perivascular/peribronchiolar lymphocytic infiltrates not present in their unvaccinated counterparts, and they appeared to be resolving lesions by day 56 compared to the other two strains, based on significantly lower disease scores and observably smaller and fewer lesions with few spherules and neutrophils.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852250      PMCID: PMC2583549          DOI: 10.1128/IAI.00885-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  40 in total

Review 1.  Coccidioidomycosis. Part I.

Authors:  D J Drutz; A Catanzaro
Journal:  Am Rev Respir Dis       Date:  1978-03

2.  Mechanisms of resistance to infection with Coccidioides immitis in mice.

Authors:  L V Beaman; D Pappagianis; E Benjamini
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

3.  Immunization of mice against coccidioidomycosis with a subcellular vaccine.

Authors:  D Pappagianis; R Hector; H B Levine; M S Collins
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

4.  Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.

Authors:  K Li; J J Yu; C Y Hung; P F Lehmann; G T Cole
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Systemic Coccidioides immitis infection in nude and beige mice.

Authors:  K V Clemons; C R Leathers; K W Lee
Journal:  Infect Immun       Date:  1985-03       Impact factor: 3.441

6.  Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection.

Authors:  T N Kirkland; J Fierer
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

7.  Significance of T cells in resistance to experimental murine coccidioidomycosis.

Authors:  L Beaman; D Pappagianis; E Benjamini
Journal:  Infect Immun       Date:  1977-09       Impact factor: 3.441

8.  Immunopathogenesis of pulmonary granulomas in the guinea pig after infection with Mycobacterium tuberculosis.

Authors:  Oliver C Turner; Randall J Basaraba; Ian M Orme
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Contribution of complement component C5 to the pathogenesis of experimental murine cryptococcosis.

Authors:  J C Rhodes
Journal:  Sabouraudia       Date:  1985-06

10.  Epidemiologic risk factors associated with canine systemic mycoses.

Authors:  L A Selby; S V Becker; H W Hayes
Journal:  Am J Epidemiol       Date:  1981-02       Impact factor: 4.897

View more
  20 in total

1.  Nitric oxide synthase activity has limited influence on the control of Coccidioides infection in mice.

Authors:  Angel Gonzalez; Chiung-Yu Hung; Garry T Cole
Journal:  Microb Pathog       Date:  2011-04-14       Impact factor: 3.738

2.  Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.

Authors:  Maged Muhammed; Marta Feldmesser; Lisa F Shubitz; Michail S Lionakis; Anita Sil; Yan Wang; Justin Glavis-Bloom; Russell E Lewis; John N Galgiani; Arturo Casadevall; Dimitrios P Kontoyiannis; Eleftherios Mylonakis
Journal:  Virulence       Date:  2012-05-01       Impact factor: 5.882

3.  Differences in Host Innate Responses among Coccidioides Isolates in a Murine Model of Pulmonary Coccidioidomycosis.

Authors:  Eric R G Lewis; Victoria R David; Adina L Doyle; Khadijeh Rajabi; Jeffrey A Kiefer; Patrick Pirrotte; Bridget M Barker
Journal:  Eukaryot Cell       Date:  2015-08-14

Review 4.  Early Events in Coccidioidomycosis.

Authors:  Fariba M Donovan; Lisa Shubitz; Daniel Powell; Marc Orbach; Jeffrey Frelinger; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2019-10-16       Impact factor: 26.132

5.  A Coccidioides posadasii CPS1 Deletion Mutant Is Avirulent and Protects Mice from Lethal Infection.

Authors:  Hema P Narra; Lisa F Shubitz; M Alejandra Mandel; Hien T Trinh; Kurt Griffin; Adam S Buntzman; Jeffrey A Frelinger; John N Galgiani; Marc J Orbach
Journal:  Infect Immun       Date:  2016-09-19       Impact factor: 3.441

6.  A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge.

Authors:  Sukumar Pal; Olga V Tatarenkova; Luis M de la Maza
Journal:  Immunology       Date:  2015-10-01       Impact factor: 7.397

Review 7.  A review of innate and adaptive immunity to coccidioidomycosis.

Authors:  Chiung-Yu Hung; Amy P Hsu; Steven M Holland; Joshua Fierer
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

Review 8.  Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Authors:  Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

9.  Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials.

Authors:  Lisa F Shubitz; Hien T Trinh; Robert H Perrill; C Michael Thompson; Nathan J Hanan; John N Galgiani; David E Nix
Journal:  J Infect Dis       Date:  2014-01-12       Impact factor: 5.226

10.  Refractory disseminated coccidioidomycosis and mycobacteriosis in interferon-gamma receptor 1 deficiency.

Authors:  Donald C Vinh; Fares Masannat; Robert B Dzioba; John N Galgiani; Steven M Holland
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.